Last Price$4.3(4.0%)
Market Cap$211.4B
Last Earnings date
Jun'24
Q2 2024
$0.00
100.0% beat
$1,142.0K
73.9% miss
Next quarter EPS Estimate
($0.42)
50.0%YoY
SLN Earnings and Expectations
Revenue
Crunching data... Almost there!
SLN EPS (Earnings Per Share)
Crunching data... Almost there!
SLN Historical Revenue & EPS and Expectations
1Y
3Y
5Y
10Y
Revenue
EPS
SLN Earnings History
| Dec'14 | Mar'15 | Jun'15 | Sep'15 | Dec'15 | Mar'16 | Jun'16 | Sep'16 | Dec'16 | Mar'17 | Jun'17 | Sep'17 | Dec'17 | Mar'18 | Jun'18 | Sep'18 | Dec'18 | Mar'19 | Jun'19 | Sep'19 | Dec'19 | Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue actual | $4,000.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $385.0K | $385.0K | $8,000.0 | $8,000.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $122.0K | $122.0K | $573.0K | $573.0K | $1,988.0K | ($842.0K) | $3,144.0K | $2,701.0K | $3,156.0K | $3,414.0K | $5,722.0K | $3,643.0K | $3,371.0K | $4,765.0K | $11.4M | $9,104.0K | $2,798.0K | $2,099.0K | $12.4M | $598.0K | $1,142.0K |
| Revenue estimate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $1,609.3K | $2,375.0K | $2,375.0K | $2,375.0K | $2,375.0K | $2,375.0K | $2,375.0K | $16.5M | $2,493.8K | $3,056.2K | $2,406.2K | $7,083.0K | $5,061.2K | $9,207.3K | $4,374.3K |
| Revenue surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 95.4% | 13.7% | 32.9% | 43.7% | 140.9% | 53.4% | 41.9% | 71.1% | 356.1% | 197.9% | 16.3% | 70.4% | 145.1% | 93.5% | 73.9% |
| EPS actual | ($0.16) | ($0.11) | ($0.11) | ($0.05) | ($0.05) | ($0.10) | ($0.10) | ($0.08) | ($0.08) | ($0.12) | ($0.12) | $0.08 | $0.08 | ($0.19) | ($0.19) | ($0.21) | ($0.21) | ($0.17) | ($0.17) | ($0.22) | ($0.22) | ($0.21) | ($0.21) | ($0.33) | ($0.07) | ($0.29) | ($0.39) | ($0.33) | ($0.32) | ($0.26) | ($0.40) | ($0.22) | ($0.43) | ($0.28) | ($0.29) | ($0.22) | ($0.37) | ($0.04) | ($0.33) | $0.00 |
| EPS estimate | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ($0.58) | ($0.58) | ($0.58) | ($0.58) | ($0.58) | ($0.58) | ($0.58) | ($0.01) | ($0.12) | ($0.14) | ($0.14) | ($0.06) | ($0.10) | ($0.09) | ($0.10) |
| EPS surprise | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 50.2% | 32.3% | 42.7% | 44.4% | 54.9% | 30.5% | 61.8% | 3,130.7% | 135.3% | 109.6% | 58.9% | 479.2% | 55.7% | 270.5% | 100.0% |
Overview of financial statements
Income statement
Balance sheet
Cash Flow statement
$1,486.4K (59.2%) YoY
Cost of revenue
$3,610.5K 72.6% YoY
Operating
expenses
$27.2M 50.5% YoY
Other: $35.2M
Competing with SLN Earnings
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Revenue | EPS | Last quarter Revenue growth | Last quarter EPS growth | Last quarter Revenue surprise | Last quarter EPS surprise | Next quarter Revenue growth | Next quarter EPS growth | Last 10 Earnings (how many miss vs beat) | 1Y Fwd Revenue growth | 1Y Fwd EPS growth |
$211.4B | £16.2M | (£0.74) | (59.2%) | (100.0%) | Miss by 87.6% | Miss by 100.0% | 490.2% | 0.0% | Beats: 5 Misses: 4 | (18.3%) | (64.1%) | |
$402.0B | DKK 290.4B | DKK 22.67 | 30.1% | 28.9% | Beat by 7.6% | Beat by 5.2% | (7.2%) | 1.8% | Beats: 5 Misses: 5 | 19.9% | 23.5% | |
$125.5B | $11.0B | ($2.06) | 15.7% | (5.6%) | Beat by 4.5% | Miss by 11.1% | (3.9%) | 23.5% | Beats: 8 Misses: 2 | 6.8% | (988.1%) | |
$74.0B | $14.2B | $40.88 | 10.3% | (21.6%) | Beat by 0.8% | Miss by 24.2% | (7.6%) | 23.7% | Beats: 7 Misses: 3 | 3.4% | 9.5% | |
$38.1B | $2,258.9M | ($1.77) | 73.8% | N/A | Beat by 40.1% | Miss by 281.3% | 23.0% | (6.7%) | Beats: 8 Misses: 2 | 76.7% | (141.9%) | |
$31.3B | $2,248.2M | ($2.17) | 34.9% | (40.9%) | Beat by 1.6% | Beat by 27.8% | (7.3%) | 14.2% | Beats: 7 Misses: 3 | 16.9% | (55.3%) | |
$27.1B | €3,040.1M | (€1.96) | 39.0% | 20.3% | Beat by 761.0% | Miss by 141.1% | (10.3%) | (51.6%) | Beats: 5 Misses: 5 | (28.2%) | (182.9%) | |
$14.8B | $4,241.2M | $0.24 | 16.3% | 7.8% | Beat by 3.4% | Miss by 35.6% | (14.7%) | 12.1% | Beats: 3 Misses: 7 | 9.3% | 3,612.9% | |
$14.6B | $0.0 | ($0.22) | (100.0%) | (100.0%) | undefinedN/A | undefinedN/A | 0.0% | 0.0% | Beats: Misses: | N/A | 6.8% | |
$14.0B | $2,877.4M | $26.45 | 19.7% | 45.9% | Miss by 0.5% | Beat by 2.4% | 3.0% | 6.7% | Beats: 5 Misses: 5 | 10.7% | 9.9% |
FAQ
1. When was Silence Therapeutics plc's last earnings date?
Silence Therapeutics plc's last earnings date was Jun'24 (Q2 2024).
2. What is Silence Therapeutics plc's EPS, and was there a surprise?
Silence Therapeutics plc's EPS was $0.00, with a 100.0% beat.
3. What is Silence Therapeutics plc's revenue, and was there a surprise?
Silence Therapeutics plc's revenue was $1,142.0K, with a 73.9% miss.
4. What is Silence Therapeutics plc's next quarter EPS estimate?
Silence Therapeutics plc's next quarter EPS estimate is ($0.42), with an expected 50.0% YoY growth.